摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(3,5-di-tert-butyl-4-hydroxy-phenyl)-propan-1-one | 14035-34-8

中文名称
——
中文别名
——
英文名称
1-(3,5-di-tert-butyl-4-hydroxy-phenyl)-propan-1-one
英文别名
2,6‐bis(1,1‐dimethylethyl)‐4‐(1‐oxopropyl)phenol;1-(3,5-Di-tert-butyl-4-hydroxy-phenyl)-propan-1-on;1-(3,5-di-tert.butyl-4-hydroxyphenyl)-propanone;3,5-di(t-butyl)-4-hydroxypropiophenone;2,6-Bis(1,1-dimethylethyl)-4-(1-oxopropyl)phenol;1-(3,5-ditert-butyl-4-hydroxyphenyl)propan-1-one
1-(3,5-di-<i>tert</i>-butyl-4-hydroxy-phenyl)-propan-1-one化学式
CAS
14035-34-8
化学式
C17H26O2
mdl
MFCD00432959
分子量
262.392
InChiKey
JGJQYHBWTHQSPR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    136 °C(Solv: ligroine (8032-32-4))
  • 沸点:
    325.0±37.0 °C(Predicted)
  • 密度:
    0.974±0.06 g/cm3(Predicted)
  • 保留指数:
    1635;1644

计算性质

  • 辛醇/水分配系数(LogP):
    5.1
  • 重原子数:
    19
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.59
  • 拓扑面积:
    37.3
  • 氢给体数:
    1
  • 氢受体数:
    2

SDS

SDS:000dac19cfb1d465ae98653f4420572c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
    申请人:——
    公开号:US20040132788A1
    公开(公告)日:2004-07-08
    The invention relates to thiazole, oxazole, imidazole, isoxazole and isoxazoline derivatives of general formula (I) 1 wherein Het is thiazole, oxazole, imidazole, isoxazole or isoxazoline, n is an integer from 0 to 6, A is notably selected from various optionally substituted aromatic radicals, B is notably hydrogen, alkyl or phenyl, R 1 and R 2 are notably independently hydrogen, alkyl or cycloalkyl and &OHgr; is —NR 46 R 47 or —OR 48 R 46 and R 47 are notably independently hydrogen, alkyl, cycloalkyl or —(CH 2 ) k —COOR 51 , R 51 is notably alkyl or haloalkyl and R 48 is notably hydrogen or alkyl. These compounds have advantageous pharmacological properties which allow their use in therapeutics, notably for treating neurodegenerative disorders or pain.
    本发明涉及噻唑、噁唑、咪唑、异噁唑和异噁唑啉的一般式(I)衍生物,其中Het为噻唑、噁唑、咪唑、异噁唑或异噁唑啉,n为0至6的整数,A特别选自各种可任选取代的芳香族基团,B特别为氢、烷基或苯基,R1和R2特别独立地为氢、烷基或环烷基,Ω为—NR46R47或—OR48,R46和R47特别独立地为氢、烷基、环烷基或—(CH2)k—COOR51,R51特别为烷基或卤代烷基,R48特别为氢或烷基。这些化合物具有有利的药理学特性,使其可用于治疗学,特别是用于治疗神经退行性疾病或疼痛。
  • Reactions of 4-bromo-4-(1-hydroxypropyl)-2,6-di-t-butylcyclohexa-2,5-dienone in methanolic sulphuric acid
    作者:Matti Karhu
    DOI:10.1039/p19800001595
    日期:——
    Reactions of the title compound (1) in methanolic sulphuric acid are described. At high acid concentrations the main reaction is the cleavage of the side chain as propionic aldehyde. At low acid concentrations the products are mainly formed by hydrolysis of (1) and subsequent reduction and oxidation reactions involving the bromide ion and bromine.
    描述了标题化合物(1)在甲醇硫酸中的反应。在高酸浓度下,主要反应是作为丙醛的侧链裂解。在低酸浓度下,产物主要由(1)的水解以及随后的涉及溴离子和溴的还原和氧化反应形成。
  • Formation of diphenyl ethers from cyclohexa-2,5-dienones via 4-phenoxy-4-(1-alkoxy)cyclohexa-2,5-dienones as probable intermediates
    作者:Matti Karhu
    DOI:10.1039/p19810000303
    日期:——
    Acid-catalysed reactions of the cyclohexa-2,5-dienones (3) and (14) with phenol afford diphenyl ethers. Quinol ethers are considered to be intermediates in these reactions, with aromatisation of the cyclohexa-2,5-dienone ring by loss of the 4-(1-alkoxy) side-chain as an aldehyde constituting the driving force.
    环己-2,5-二烯酮(3)和(14)与苯酚的酸催化反应得到二苯醚。喹诺醚被认为是这些反应的中间体,通过失去作为驱动力的醛的4-(1-烷氧基)侧链,使环己-2,5-二烯酮环芳构化。
  • Influence of the redox state of the ligand on the dealkylation of substituted methylcobaloximes in the presence of heavy metal ions
    作者:E. R. Milaeva、A. V. Androsova、O. V. Polyakova、A. I. Prokof'ev、V. S. Petrosyan
    DOI:10.1007/bf01431816
    日期:1996.7
    Pb4+ ions, The free radical forms of the complexes containing a phenoxy radical W the ligand are formed during oxidation. The ESR spectra are given. The unpaired electron in the periphery of the methylcobaloxime ligand1c interacts with the Co-CH3 fragment through the conjugated systems, enhancing the donating properties of the equatorial ligand of the complex, which leads to the rapid cleavage of the
    描述了在配体中含有位阻 2,6-二叔丁基苯酚片段的钴肟和甲基钴肟的合成。甲基双(二甲基乙醛肟)钴(1a)、甲基双(二苯基乙醛肟)钴(1b)、甲基双[甲基-(3,5-二-叔丁基-4-羟基苯基)乙醛肟]钴(1c)吡啶盐的去甲基化的光谱研究在 Cd2+、Hg2+、Sn4+、Pb2+ 和 Pb4+ 离子的存在下进行。氧化过程中形成含有苯氧基自由基 W 的配合物的自由基形式。给出了 ESR 谱。甲基钴肟配体 1c 外围的未配对电子通过共轭系统与 Co-CH3 片段相互作用,增强了配合物赤道配体的捐赠特性,从而导致 Co-C 键的快速断裂。
  • 4-PHENYL-1,3-THIAZOLES AND 4-PHENYL-1,3-OXAZOLES DERIVATIVES AS CANNABINOID RECEPTOR LIGANDS
    申请人:Harnett Jeremiah
    公开号:US20110059970A1
    公开(公告)日:2011-03-10
    The present invention relates to new 4-phenyl-1,3-azole derivatives having the general formula (I) wherein R1, R2, R3, R4, X, A, B, and n are variable, in a racemic form, an enantiomeric form or any combinations thereof. These compounds exhibit affinity for cannabinoid receptors and may therefore be used as drugs to treat or prevent pathological states and diseases in which one or more of these receptors are involved. The invention also relates to pharmaceutical compositions containing said products and to the use thereof to prepare a drug.
    本发明涉及具有一般式(I)的新4-苯基-1,3-唑衍生物,其中R1、R2、R3、R4、X、A、B和n是可变的,在消旋形式、对映异构体形式或任何组合中。这些化合物对大麻素受体具有亲和力,因此可用作药物治疗或预防涉及其中一个或多个这些受体的病理状态和疾病。本发明还涉及含有所述产品的药物组合物以及利用它们制备药物的用途。
查看更多